Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Mar-24 5:33 PM View:  | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Mar-24 | Sale | 90,000 | $30.60 | $2,754,000.00 | (80%) 112.13K to 22.13K | |
| 08-Mar-24 5:33 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Mar-24 | Sale | 28,257 | $30.81 | $870,598.00 | (20%) 140.38K to 112.13K | |
| 08-Mar-24 5:33 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Mar-24 | Sale | 1,066 | $29.67 | $31,628.20 | (< 1%) 141.45K to 140.38K | |
| 07-Feb-24 4:59 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Feb-24 | Grant | 33,700 | -- | -- | 133% 25.38K to 59.08K | |
| 07-Feb-24 4:59 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Feb-24 | Grant | 33,700 | -- | -- | 106% 31.79K to 65.49K | |
| 04-Jan-24 5:25 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Payment of Exercise | 159 | $32.00 | $5,088.00 | (< 1%) 22.69K to 22.53K | |
| 04-Jan-24 5:21 PM View: | Lee Frank D. Chief Executive Officer Director | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Grant | 99,520 | -- | -- | 100% 0 to 99.52K | |
| 04-Jan-24 5:24 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Grant | 5,000 | -- | -- | 11% 46.2K to 51.2K | |
| 04-Aug-23 4:47 PM View: | Winston Roy Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Aug-23 | Sale | 509 | $34.88 | $17,751.40 | (< 1%) 52.95K to 52.44K | |
| 07-Jul-23 8:04 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jul-23 | Sale (Planned) | 643 | $38.91 | $25,019.10 | (3%) 23.33K to 22.69K | |
| 12-Jun-23 4:16 PM View: | Kronenfeld Mark A. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-23 | Option Exercise | 15,000 | $29.90 | $448,500.00 | 84% 17.9K to 32.9K | |
| 12-Jun-23 4:16 PM View: | Kronenfeld Mark A. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-23 | Planned Option Sale | 15,000 | $37.04 | $555,600.00 | (46%) 32.9K to 17.9K | |
| 07-Jun-23 9:33 PM View: | Stack David M CEO and Chairman Director | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 5,326 | $37.87 | $201,669.00 | (2%) 275.29K to 269.96K | |
| 07-Jun-23 9:24 PM View: | McLoughlin Dennis Chief Customer Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,057 | $37.87 | $40,023.30 | (3%) 39.17K to 38.12K | |
| 07-Jun-23 9:36 PM View: | Winston Roy Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,857 | $37.87 | $70,315.30 | (4%) 43.21K to 41.36K | |
| 07-Jun-23 9:29 PM View: | Reinhart Charles A. III Chief Financial Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,371 | $37.87 | $51,912.90 | (4%) 35.0K to 33.63K | |
| 07-Jun-23 9:31 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 616 | $37.87 | $23,324.80 | (3%) 19.67K to 19.05K | |
| 07-Jun-23 9:22 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,047 | $37.87 | $39,644.70 | (5%) 22.59K to 21.54K | |
| 07-Jun-23 9:20 PM View: | Ellis Ronald J. Jr. Chief Strategy Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,162 | $37.87 | $43,999.10 | (4%) 32.07K to 30.91K | |
| 07-Jun-23 9:32 PM View: | Slonin Jonathan Chief Clinical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 490 | $37.87 | $18,553.90 | (1%) 36.81K to 36.32K | |
| 07-Jun-23 9:34 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,357 | $37.87 | $51,382.80 | (6%) 22.25K to 20.89K | |
| 07-Jun-23 9:28 PM View: | Reinhardt Max President, Rest of World | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,099 | $37.87 | $41,613.60 | (4%) 30.32K to 29.23K | |
| 07-Jun-23 9:31 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 591 | $38.99 | $23,043.70 | (3%) 20.26K to 19.67K | |
| 07-Jun-23 9:22 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,005 | $38.99 | $39,186.00 | (4%) 23.59K to 22.59K | |
| 07-Jun-23 9:20 PM View: | Ellis Ronald J. Jr. Chief Strategy Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,114 | $38.99 | $43,436.00 | (3%) 33.19K to 32.07K | |
| 07-Jun-23 9:26 PM View: | Molloy Anthony Chief Lgl & Compliance Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale (Planned) | 4,521 | $38.55 | $174,285.00 | (26%) 17.4K to 12.88K | |
| 07-Jun-23 9:32 PM View: | Slonin Jonathan Chief Clinical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 471 | $38.99 | $18,364.80 | (1%) 37.28K to 36.81K | |
| 07-Jun-23 9:34 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,301 | $38.99 | $50,727.30 | (6%) 23.55K to 22.25K | |
| 07-Jun-23 9:28 PM View: | Reinhardt Max President, Rest of World | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,054 | $38.99 | $41,096.50 | (3%) 31.38K to 30.32K | |
| 07-Jun-23 9:33 PM View: | Stack David M CEO and Chairman Director | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 5,058 | $38.99 | $197,216.00 | (2%) 280.35K to 275.29K | |
| 07-Jun-23 9:24 PM View: | McLoughlin Dennis Chief Customer Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,014 | $38.99 | $39,536.90 | (3%) 40.19K to 39.17K | |
| 07-Jun-23 9:36 PM View: | Winston Roy Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,779 | $38.99 | $69,365.00 | (4%) 44.99K to 43.21K | |
| 07-Jun-23 9:29 PM View: | Reinhart Charles A. III Chief Financial Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,236 | $38.99 | $48,192.90 | (3%) 36.23K to 35.0K | |
| 07-Jun-23 9:23 PM View: | Hastings Paul J Director | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale | 580 | $38.34 | $22,236.60 | (8%) 7.18K to 6.6K | |
| 07-Jun-23 9:22 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale (Planned) | 1,000 | $38.74 | $38,740.00 | (4%) 24.59K to 23.59K | |
| 07-Jun-23 9:26 PM View: | Molloy Anthony Chief Lgl & Compliance Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale | 2,267 | $38.28 | $86,774.00 | (12%) 19.66K to 17.4K | |
| 07-Jun-23 9:18 PM View: | Brege Laura Director | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale (Planned) | 600 | $38.74 | $23,244.00 | (6%) 10.15K to 9.55K | |
| 02-Jun-23 6:28 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 31-May-23 | Option Exercise | 2,500 | $34.00 | $85,000.00 | 10% 24.59K to 27.09K | |
| 02-Jun-23 6:28 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 31-May-23 | Planned Option Sale | 2,500 | $39.08 | $97,700.00 | (9%) 27.09K to 24.59K | |
| 17-May-23 4:07 PM View: | Hastings Paul J Director | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-23 | Option Exercise | 7,000 | $29.90 | $209,300.00 | 98% 7.18K to 14.18K | |
| 17-May-23 4:07 PM View: | Hastings Paul J Director | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-23 | Planned Option Sale | 7,000 | $41.85 | $292,950.00 | (49%) 14.18K to 7.18K | |
| 15-May-23 6:53 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 11-May-23 | Option Exercise | 7,000 | $29.90 | $209,300.00 | 5% 137.69K to 144.69K | |
| 15-May-23 6:53 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 11-May-23 | Option Sale | 5,015 | $41.78 | $209,527.00 | (3%) 144.69K to 139.68K | |
| 05-Apr-23 4:34 PM View: | Brege Laura Director | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Apr-23 | Option Exercise | 7,000 | $29.90 | $209,300.00 | 69% 10.15K to 17.15K | |
| 05-Apr-23 4:34 PM View: | Brege Laura Director | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Apr-23 | Planned Option Sale | 7,000 | $40.72 | $285,040.00 | (41%) 17.15K to 10.15K | |
| 06-Jan-23 7:04 PM View: | Molloy Anthony Chief Lgl & Compliance Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jan-23 | Sale (Planned) | 546 | $38.31 | $20,917.30 | (3%) 20.0K to 19.45K | |
| 06-Jan-23 7:04 PM View: | Molloy Anthony Chief Lgl & Compliance Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jan-23 | Sale | 158 | $39.09 | $6,176.69 | (< 1%) 20.15K to 20.0K | |
| 11-Oct-22 4:13 PM View: | Reinhardt Max President, Rest of World | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Oct-22 | Market Sale (Planned) | 1,380 | $58.00 | $80,040.00 | (4%) 32.76K to 31.38K | (6%) |
| 05-Aug-22 4:04 PM View: | Slonin Jonathan Chief Clinical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Aug-22 | Market Sale | 308 | $55.70 | $17,155.60 | (< 1%) 37.39K to 37.08K | (10%) |
| 05-Aug-22 4:06 PM View: | Winston Roy Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Aug-22 | Market Sale | 476 | $55.70 | $26,513.20 | (1%) 45.47K to 44.99K | (10%) |
